Operator says targeted small cell deployments are becoming essential as mobile traffic continues to climb and planning delays ...

Crown Castle CEO outlines post-fiber strategy to grow tower REIT via tenant services, edge compute and AI-ready platforms.

Headquartered in Houston, Crown Castle is a telecommunications company. Also, as part of the transaction, Zayo, backed by EQT, will independently acquire Crown Castle’s fiber solutions business The ...

Trudy Oliver, professor of pharmacology and cancer biology, is part of a team of scientists that recently published a study uncovering a major shift in how scientists understand small-cell lung cancer ...

Chemotherapy is a treatment that may be used for non-small cell lung cancer. It’s often used in combination with other treatment types. Chemotherapy is associated with a variety of risks and benefits.

A small cell lung cancer (SCLC) misdiagnosis is possible. This can occur because of challenges during the diagnostic tests and because SCLC may share symptoms and causes similar to other conditions.

Despite recent advances in immunotherapy and targeted therapy, most patients with non-small-cell lung cancer (NSCLC) continue to have disease progression and develop resistance to current treatments.

Most people with small cell lung cancer will have a recurrence. While several factors affect life expectancy, the outlook is typically less favorable. Treatment for recurrent small cell lung cancer is ...